Cancer Treatment
New findings from the United States and China in the area of cancer treatment described
Published in Gene Therapy Weekly, May 11th, 2006
Study 1: According to a study from the United States, allogeneic tumor cells expressing fusogenic membrane glycoproteins (FMG) enable clinical cancer immunotherapy.
"FMG, such as the vesicular stomatitis virus G glycoprotein (VSV-G), represent a new class of gene therapy for cancer that cause cytotoxic fusion on expression in tumor cells. In addition, FMG-mediated tumor cell death stimulates antitumor immunity, suggesting potential applications for FMG-expressing cellular vaccines.
"This study addresses the promise of FMG-expressing allogeneic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-05-11)
More Articles from Gene Therapy Weekly
- Antisense Technology
Antisense oligodeoxynucleotides can be delivered from cationically modified polymer films - Antisense Technology
Morpholino antisense oligonucleotides inhibit Oct4 expression - Cancer Gene Therapy
Breast cancer cell invasiveness is affected by matrix metalloproteinase - Gene Therapy
Calcitonin gene-related peptide receptor is activated by gene transfer - Gene Transfer
Gene transfer and enzyme replacement eliminates abnormal fibroblast sialylglycoproteins - Alveolar Cancer
Bronchoalveolar cell carcinoma is reduced by gene-modified dendritic cells - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
